TVARDI THERAPEUTICS, INC.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Mar 2014 | $178.0K | $-3.4M | $-3.4M |
| Jun 2014 | $960.0K | $-3.7M | $-3.6M |
| Sep 2014 | $1.1M | $-6.6M | $-6.5M |
| Dec 2014 | $914.0K | — | $-4.2M |
| Mar 2015 | $489.0K | $-4.7M | $-4.7M |
| Jun 2015 | $874.0K | $-5.7M | $-5.7M |
| Sep 2015 | $2.4M | $-5.0M | $-4.8M |
| Dec 2015 | — | — | $-9.5M |
| Mar 2016 | $7.0K | $-11.0M | $-10.7M |
| Jun 2016 | $79.0K | $-13.3M | $-13.1M |
| Sep 2016 | — | $-11.8M | $-11.5M |
| Dec 2016 | — | — | $-22.0M |
| Mar 2017 | $911.0K | $-22.3M | $-22.2M |
| Jun 2017 | — | $-9.6M | $-9.3M |
| Sep 2017 | — | $-13.0M | $-12.4M |
| Dec 2017 | — | — | $-14.2M |
| Mar 2018 | — | $-17.1M | $-16.8M |
| Jun 2018 | $2.9M | $-17.8M | $-17.2M |
| Sep 2018 | $5.1M | $-20.5M | $-19.4M |
| Dec 2018 | $5.5M | — | $-20.7M |
| Mar 2019 | $4.4M | $-23.1M | $-22.0M |
| Jun 2019 | $5.2M | $-24.1M | $-23.0M |
| Sep 2019 | $5.8M | $-34.4M | $-32.8M |
| Dec 2019 | $4.5M | — | $-28.6M |
| Mar 2020 | $8.1M | $-30.0M | $-28.9M |
| Jun 2020 | $5.6M | $-25.9M | $-25.1M |
| Sep 2020 | $9.3M | $-17.0M | $-16.5M |
| Dec 2020 | $112.1M | — | $78.9M |
| Mar 2021 | $1.9M | $-23.6M | $-23.3M |
| Jun 2021 | — | $-30.9M | $-30.7M |
| Sep 2021 | $20.3M | $-1.1M | $-1.0M |
| Mar 2022 | $4.8M | $-27.9M | $-27.7M |
| Jun 2022 | $23.0M | $-4.5M | $-4.2M |
| Sep 2022 | $10.8M | $-23.8M | $-23.2M |
| Mar 2023 | $6.2M | $-27.7M | $-26.7M |
| Jun 2023 | $6.9M | $-32.3M | $-31.5M |
| Sep 2023 | $4.9M | $-28.9M | $-28.0M |
| Mar 2024 | $2.1M | $-29.7M | $-4.2M |
| Jun 2024 | $991.0K | $-7.2M | $-7.0M |
| Sep 2024 | $2.6M | $-5.7M | $-5.5M |
| Mar 2025 | $2.6M | $-4.4M | $-9.6M |
| Jun 2025 | — | $-8.9M | $4.2M |
| Sep 2025 | — | $-5.9M | $-5.5M |
| Mar 2026 | — | $-7.1M | $-6.8M |
| Jun 2026 | — | $-6.6M | $-6.5M |